feed,title,long_url,short_url
SeekingAlpha,Atossa Therapeutics prices $14M registered direct offering,https://seekingalpha.com/news/3645338,
SeekingAlpha,Horizon expects short-term disruption in Tepezza supply into next quarter,https://seekingalpha.com/news/3645336,
SeekingAlpha,NextCure provides update on NC318 clinical program,https://seekingalpha.com/news/3645337,
